FRCPath Haem Part 1 MCQ-Oncology 146
- amirhayat2527
- Oct 9
- 0 min read
According to current UK practice, Pembrolizumab can be offered for classical Hodgkin lymphoma in which of the following scenarios?
As first-line therapy for advanced-stage disease
After two prior therapies, including brentuximab, ASCT Unfit
As maintenance therapy after autologous stem cell transplant
In combination with ABVD as initial therapy
